AMY BURKHART: Open Payments
NPI 1255820619 · BETTENDORF, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 10 payments from 6 companies in 2025. Trend: 2023 $225 · 2024 $317 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $71 |
| Gilead Sciences, Inc. | 2 | $51 |
| Celltrion USA Inc. | 2 | $44 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $20 |
| Boston Scientific Corporation | 1 | $19 |
Products named: SKYRIZI, VEGZELMA, ZENPEP, RINVOQ, IBSRELA, WATCHMAN Access System.
Industry payments across IA — which companies pay providers there.
